Berlin, Germany

Peter Holscher


Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 1998-2006

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovative Contributions of Inventor Peter Holscher

Introduction

Peter Holscher, a prominent inventor based in Berlin, Germany, has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a total of six patents, Holscher's work primarily focuses on the development of compounds that address critical health issues.

Latest Patents

Holscher's latest patents include groundbreaking formulations and applications of aminoalkyl-3, 4-dihydroquinoline derivatives. These compounds serve as inhibitors of nitrogen monoxide synthase, which is essential for treating diseases influenced by abnormal nitric oxide levels in the body. The patents describe not only the chemical structures but also detailed processes for their production and potential uses in pharmaceutical agents.

Career Highlights

Throughout his career, Holscher has worked with well-respected companies in the pharmaceutical industry, including Schering Aktiengesellschaft. His experience in these leading organizations has allowed him to refine his research skills and develop innovative solutions that contribute to the advancement of medical science.

Collaborations

Peter Holscher has collaborated with notable colleagues, such as Hartmut Rehwinkel and Gerardine Anne Burton. These partnerships have played a vital role in the development of his inventions and have facilitated the exchange of ideas that spur further innovation.

Conclusion

Peter Holscher's contributions to pharmaceutical inventions, particularly in the realm of nitrogen monoxide synthase inhibitors, demonstrate the profound impact that dedicated inventors can have on public health. With his ongoing work and collaborations, Holscher continues to push the boundaries of innovation in the medical sector, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…